Displaying 61 - 80 of 213
FTC Approves Final Order Imposing Conditions on UnitedHealth Group’s Proposed Acquisition of DaVita Medical Group
UnitedHealth Group/DaVita, In the Matter of
The Federal Trade Commission has imposed conditions on UnitedHealth Group’s proposed acquisition of DaVita Medical Group. In its complaint, the FTC alleged that the proposed $4.3 billion acquisition would harm competition in healthcare markets in two Nevada counties, Clark and Nye. Under the proposed settlement, the FTC required UnitedHealth Group to divest DaVita’s HealthCare Partners of Nevada to Intermountain Healthcare. The Commission announced on Aug. 22, 2019 that the settlement was made final.
After Healthcare System Sanford Health Abandons Acquisition of North Dakota Healthcare Provider Mid Dakota Clinic, FTC Dismisses Case from Administrative Trial Process
UnitedHealth Group and DaVita; Analysis of Agreement Containing Consent Orders To Aid Public Comment
Joint Statement of Commissioners Phillips and Wilson Concerning UnitedHealth Group and DaVita
Joint Statement of Commissioners Rohit Chopra and Rebecca Kelly Slaughter Concerning UnitedHealth Group and DaVita
FTC Imposes Conditions on UnitedHealth Group’s Proposed Acquisition of DaVita Medical Group
FTC to Hold Workshop Tomorrow Regarding the Impact of Certificates of Public Advantage
FTC Announces Agenda for June 18 Workshop, A Health Check on COPAs
FTC to Hold Workshop on Certificates of Public Advantage in Healthcare Markets
FTC Approves Final Order Imposing Conditions on Merger of Fresenius Medical Care AG & KGaA and NxStage Medical, Inc.
A Health Check on COPAs: Assessing the Impact of Certificates of Public Advantage in Healthcare Markets
Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA
Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
FTC Requires Fresenius Medical Care AG & KGaA and NxStage Medical, Inc. to Divest Bloodline Tubing Assets to B. Braun Medical, Inc. as a Condition of Merger
Displaying 61 - 80 of 213